Imprivata (NYSE:IMPR) Getting Positive News Coverage, Study Finds

News coverage about Imprivata (NYSE:IMPR) has trended positive this week, according to Accern. Accern scores the sentiment of media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Imprivata earned a daily sentiment score of 0.28 on Accern’s scale. Accern also gave news articles about the technology company an impact score of 44.8536961565801 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Shares of Imprivata (NYSE IMPR) opened at $19.26 on Monday. Imprivata has a 52-week low of $9.00 and a 52-week high of $20.32.

TRADEMARK VIOLATION WARNING: This story was posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://ledgergazette.com/2017/11/13/imprivata-impr-earning-favorable-news-coverage-study-finds.html.

Imprivata Company Profile

Imprivata, Inc (Imprivata) is a United States-based healthcare information technology security company. The Company enables healthcare organizations to access, communicate and transact patient information securely. The Company offers Imprivata OneSign, Imprivata Cortext, Imprivata Confirm ID and Imprivata PatientSecure.

Insider Buying and Selling by Quarter for Imprivata (NYSE:IMPR)

Receive News & Ratings for Imprivata Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imprivata Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply